tiprankstipranks
Living Cell Technologies Ltd. (LVCLF)
OTHER OTC:LVCLF

Living Cell Technologies Ltd. (LVCLF) Stock Price & Analysis

1 Followers

LVCLF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume47.50K
Average Volume (3M)N/A
Market Cap
$11.66M
Enterprise Value$8.94M
Total Cash (Recent Filing)AU$4.24M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-13.3
Beta2.10
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.27
R-Squared0.02
Alpha0.00331
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

7.29%0.00%0.00%92.71%
0.00% Other Institutional Investors
92.71% Public Companies and
Individual Investors

LVCLF FAQ

What was Living Cell Technologies Ltd.’s price range in the past 12 months?
Living Cell Technologies Ltd. lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
    What is Living Cell Technologies Ltd.’s market cap?
    Currently, no data Available
    When is Living Cell Technologies Ltd.’s upcoming earnings report date?
    Living Cell Technologies Ltd.’s upcoming earnings report date is Aug 28, 2024 which is in 121 days.
      How were Living Cell Technologies Ltd.’s earnings last quarter?
      Living Cell Technologies Ltd. released its earnings results on Feb 28, 2024. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
        Is Living Cell Technologies Ltd. overvalued?
        According to Wall Street analysts Living Cell Technologies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Living Cell Technologies Ltd. pay dividends?
          Living Cell Technologies Ltd. does not currently pay dividends.
          What is Living Cell Technologies Ltd.’s EPS estimate?
          Living Cell Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Living Cell Technologies Ltd. have?
          Living Cell Technologies Ltd. has 1,661,240,200 shares outstanding.
            What happened to Living Cell Technologies Ltd.’s price movement after its last earnings report?
            Living Cell Technologies Ltd. reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Living Cell Technologies Ltd.?
              Currently, no hedge funds are holding shares in LVCLF
              ---

              Living Cell Technologies Ltd. Stock Smart Score

              4
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -68.84%
              Trailing 12-Months
              Asset Growth
              21.41%
              Trailing 12-Months

              Company Description

              Living Cell Technologies Ltd.

              Living Cell Technologies Ltd. is a biotechnology company. It engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Auckland, New Zealand.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Lexicon Pharmaceuticals
              Novartis
              BioCryst
              ImmunoCellular Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis